Found: 82
Select item for more details and to access through your institution.
Discovering genetic biomarkers for targeted cancer therapeutics with eXplainable Artificial Intelligence.
- Published in:
- Cancer Communications, 2024, v. 44, n. 5, p. 584, doi. 10.1002/cac2.12530
- By:
- Publication type:
- Article
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1278, doi. 10.3390/ijms25021278
- By:
- Publication type:
- Article
An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.
- Published in:
- Non-Coding RNA, 2023, v. 9, n. 6, p. 70, doi. 10.3390/ncrna9060070
- By:
- Publication type:
- Article
Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.
- Published in:
- 2023
- By:
- Publication type:
- Product Review
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5300, doi. 10.3390/cancers15215300
- By:
- Publication type:
- Article
Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment.
- Published in:
- Non-Coding RNA, 2023, v. 9, n. 5, p. 52, doi. 10.3390/ncrna9050052
- By:
- Publication type:
- Article
Aptamers as Insights for Targeting SARS-CoV-2.
- Published in:
- Biologics, 2023, v. 3, n. 2, p. 116, doi. 10.3390/biologics3020007
- By:
- Publication type:
- Article
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update.
- Published in:
- Non-Coding RNA, 2023, v. 9, n. 2, p. 27, doi. 10.3390/ncrna9020027
- By:
- Publication type:
- Article
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3915, doi. 10.3390/ijms24043915
- By:
- Publication type:
- Article
Redirecting host preexisting influenza A virus immunity for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1611, doi. 10.1007/s00262-021-03099-9
- By:
- Publication type:
- Article
Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3450, doi. 10.3390/cancers13143450
- By:
- Publication type:
- Article
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2487, doi. 10.3390/cancers13102487
- By:
- Publication type:
- Article
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1882, doi. 10.3390/ijms22041882
- By:
- Publication type:
- Article
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2889, doi. 10.3390/cancers12102889
- By:
- Publication type:
- Article
Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2406, doi. 10.3390/cancers12092406
- By:
- Publication type:
- Article
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Corrigendum: FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
- Published in:
- Carcinogenesis, 2019, v. 40, n. 7, p. 936, doi. 10.1093/carcin/bgz062
- By:
- Publication type:
- Article
Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/6852917
- By:
- Publication type:
- Article
Bone protection by inhibition of microRNA-182.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06446-0
- By:
- Publication type:
- Article
Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 593, doi. 10.1007/s10549-018-4847-2
- By:
- Publication type:
- Article
RNA interference-based therapy and its delivery systems.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 1, p. 107, doi. 10.1007/s10555-017-9717-6
- By:
- Publication type:
- Article
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
- Published in:
- 2018
- By:
- Publication type:
- journal article
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00411-z
- By:
- Publication type:
- Article
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to mi RNA overexpression.
- Published in:
- Molecular Systems Biology, 2015, v. 11, n. 12, p. n/a, doi. 10.15252/msb.20156308
- By:
- Publication type:
- Article
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv108
- By:
- Publication type:
- Article
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131833
- By:
- Publication type:
- Article
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TP53 loss creates therapeutic vulnerability in colorectal cancer.
- Published in:
- Nature, 2015, v. 520, n. 7549, p. 697, doi. 10.1038/nature14418
- By:
- Publication type:
- Article
STAMP2 increases oxidative stress and is critical for prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 3, p. 315, doi. 10.15252/emmm.201404181
- By:
- Publication type:
- Article
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
- Published in:
- Journal of Pathology, 2015, v. 235, n. 1, p. 25, doi. 10.1002/path.4443
- By:
- Publication type:
- Article
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5671, doi. 10.1038/ncomms6671
- By:
- Publication type:
- Article
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5092, doi. 10.1038/ncomms6092
- By:
- Publication type:
- Article
miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
- Published in:
- Nature, 2014, v. 512, n. 7515, p. 431, doi. 10.1038/nature13375
- By:
- Publication type:
- Article
RNAi Therapies: Drugging the Undruggable.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 240, p. 1, doi. 10.1126/scitranslmed.3008362
- By:
- Publication type:
- Article
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 5, p. 1100, doi. 10.1093/carcin/bgt489
- By:
- Publication type:
- Article
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.
- Published in:
- Molecular Systems Biology, 2014, v. 10, n. 5, p. n/a, doi. 10.1002/msb.20134892
- By:
- Publication type:
- Article
Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e47, doi. 10.1016/j.clml.2013.08.004
- By:
- Publication type:
- Article
Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079167
- By:
- Publication type:
- Article
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
- Published in:
- Carcinogenesis, 2012, v. 33, n. 10, p. 1843, doi. 10.1093/carcin/bgs167
- By:
- Publication type:
- Article
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041171
- By:
- Publication type:
- Article
PKCd Regulates Translation Initiation through PKR and eIF2a in Response to Retinoic Acid in Acute Myeloid Leukemia Cells.
- Published in:
- Leukemia Research & Treatment, 2012, p. 1, doi. 10.1155/2012/482905
- By:
- Publication type:
- Article
Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 21, p. 1596, doi. 10.1093/jnci/djr372
- By:
- Publication type:
- Article
Neuropilin-2 Mediated b-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0023208
- By:
- Publication type:
- Article
Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021121
- By:
- Publication type:
- Article
Cardiotoxicity due to Cancer Therapy.
- Published in:
- Texas Heart Institute Journal, 2011, v. 38, n. 3, p. 253
- By:
- Publication type:
- Article
Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017918
- By:
- Publication type:
- Article
RNA interference in the clinic: challenges and future directions.
- Published in:
- 2011
- By:
- Publication type:
- journal article